MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "etc): Clinical features"

  • 2017 International Congress

    Examining central cognitive processing speed as an early marker of Huntington’s disease (HD) onset

    A. Nathan, S. Park, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

    Objective: To examine central processing speed as an early marker of Huntington’s disease (HD) onset using the Computerized Test of Information Processing (CTiP). Background: The CTiP,…
  • 2017 International Congress

    Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes

    F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the relationship between Huntington’s Disease and depression. Background: Huntington’s Disease (HD) is an uncommon genetic neurodegenerative disorder in the United States…
  • 2017 International Congress

    Salivary biomarkers for Huntington’s disease (HD)

    J. Corey-Bloom, A. Aikin, S. Park, A. Haque, A. Nathan, D. Granger, S. Granger, E. Thomas (La Jolla, CA, USA)

    Objective: The objective of the current study was to assess the potential for saliva to serve as a biospecimen for accessible biomarkers for Huntington’s disease…
  • 2017 International Congress

    Social hindrances for diagnosing Huntington’s disease

    A. Alboudi, P. Sarathchandran, A.B. Almadani (Dubai, United Arab Emirates)

    Objective: The need to differentiate the malingering from real complains Careful history can give a strong clue for the diagnosis Criminals can have diseases also…
  • 2017 International Congress

    Behavioral Changes on the UCSD Huntington’s Disease Behavioral Questionnaire (HD-BQ) Distinguish Patients Transitioning to Manifest Huntington’s disease (HD)

    S. Park, S. Nam, A. Nathan, A. Haque, A. Haque, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

    Objective: To utilize the UCSD Huntington's Disease Behavioral Questionnaire (HD-BQ) to assess behavioral changes that distinguish HD gene carriers transitioning to manifest HD. Background: Behavioral…
  • 2017 International Congress

    Evaluating wearable sensors for objective measurement of motor features in Parkinson disease and Huntington disease – a pilot study

    J. Adams, M. Xiong, K. Dinesh, C. Tarolli, S. Sharma, N. Sheth, A.J. Aranyosi, W. Zhu, S. Goldenthal, K. Biglan, R. Dorsey, G. Sharma (Rochester, NY, USA)

    Objective: Evaluate the feasibility of wearable sensors in measuring motor features of individuals with PD, HD, prodromal HD, and controls in clinic and at home.…
  • 2017 International Congress

    Juvenile Huntington Disease (JHD) subjects’ stratification according to the mutation-length

    M. Marano, M. Marano, S. Migliore, S. Maffi, F. Consoli, A. Ciammola, E. Gatto, F. Squitieri (Rome, Italy)

    Objective: To identify clinical and genetic markers to differ JHD from adult Huntington disease (HD) and to monitor JHD progression Background: JHD is a HD…
  • 2017 International Congress

    Eye Movements in Huntington Disease Like 2

    D. Anderson, R. Margolis, A. Krause (Johannesburg, South Africa)

    Objective: ObjectiveTo determine if eye movements are preserved in Huntington Disease-Like 2 (HDL2) and if this can be used to differentiate HDL2 from Huntington Disease…
  • 2017 International Congress

    A modified model for prediction of Huntington disease age of onset based on length of CAG repeat expansion

    Y. Seliverstov, E. Shulgina, S. Illarioshkin, M. Belyaev (Moscow, Russian Federation)

    Objective: We aimed to search for a possibility to modify Langbehn et al. model (LanM) for prediction of Huntington disease (HD) age of onset based on length of CAG…
  • 2017 International Congress

    Syndenham’s chorea in Senegalese children: A case series

    F.S. NGOUNGOURE HALIMA, M. NDIAYE, A.D. SOW, B. SECK, M.M. NDIAYE (Dakar, Senegal)

    Objective: To describe clinical profile and treatment outcome of Sydenham’s chorea (SC) in children attending a tertiary care hospital in Dakar, Senegal. Background: SC is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley